Status:
COMPLETED
Adapted Solution Focused Therapy for People With Aphasia (SOFIA Trial)
Lead Sponsor:
City, University of London
Conditions:
Aphasia
Stroke
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Around one third of stroke survivors will have aphasia, which means they will have difficulty talking, understanding, reading or writing. The main aims of this study are to assess: \[1\] the acceptabi...
Detailed Description
Background and Aims Around one third of people who have a stroke will experience aphasia, a language disability that can affect talking, understanding, reading or writing. The psychosocial impact of a...
Eligibility Criteria
Inclusion
- Inclusion criteria:
- Have a diagnosis of ischaemic or haemorrhagic stroke
- At least six months post stroke
- 18 years old or over
- Presenting with aphasia as a result of the stroke. For those participants identified via United Kingdom National Health Service (two participant identification centers), this will be determined based on Speech and Language Therapist diagnosis. For participants recruited via the community, it will be based on their scores on the Frenchay Aphasia Screening Test (FAST). This test covers four major aspects of language: comprehension, expression, reading and writing. Aphasia is determined by published cut-off scores. Where a person has mild aphasia, such that they score as 'normal' on the FAST, but where the participant self-identifies as having aphasia, and this is confirmed by the clinical judgement of the Chief Investigator, they will be included.
- Exclusion Criteria:
- Other diagnoses affecting cognition such as dementia or advanced Parkinson's Disease
- Severe uncorrected visual or hearing problems that would impact on a person's capacity to take part in the intervention
- Severe or potentially terminal co-morbidity on grounds of frailty
- Currently receiving a psychological or psychiatric intervention
- Non-fluent English speaker prior to the stroke based on self/family report
- Do not have mental capacity to consent to take part in the trial
Exclusion
Key Trial Info
Start Date :
October 17 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 14 2019
Estimated Enrollment :
32 Patients enrolled
Trial Details
Trial ID
NCT03245060
Start Date
October 17 2017
End Date
August 14 2019
Last Update
February 10 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
City, University of London
London, United Kingdom, EC1V 0HB